摘要
肥厚型心肌病(HCM)是儿童及青少年心源性猝死的最重要原因之一,自2019年国内首部中国儿童HCM诊断共识发布以来,有关HCM的诊断及管理有了新的进展。为此,中华医学会儿科学分会心血管学组儿童心肌病精准诊治协作组联合心力衰竭协作组和遗传代谢性心肌病协作组以及《中国实用儿科杂志》编辑委员会组织专家制订了该共识,着重关注儿童HCM定义、诊疗手段、危险分层及管理,旨在提高儿童HCM诊治的规范性,从而提高其生存质量并改善预后。
Hypertrophic cardiomyopathy(HCM)is one of the most important causes of sudden cardiac death in children and adolescents.Since the publication of the first Chinese consensus on pediatric HCM diagnosis in 2019,new and significant advances have been made in the diagnosis and management of HCM.To address these developments,the Cardiovascular Subspecialty Group of the Pediatrics Branch,Chinese Medical Association,in collaboration with the Precision Diagnosis and Treatment Collaborative Group for Childhood Cardiomyopathy,the Heart Failure Collaborative Group,the Genetic and Metabolic Cardiomyopathy Collaborative Group,and the Editorial Board of Chinese Journal of Practical Pediatrics,organized experts to develop this updated consensus.The consensus focuses on the definition,diagnostic approaches,risk stratification,and management of pediatric HCM,with the aim of improving the standardization of diagnosis and treatment of pediatric HCM,thereby enhancing its quality of life and improving prognosis.
出处
《中国实用儿科杂志》
北大核心
2025年第8期617-636,共20页
Chinese Journal of Practical Pediatrics
基金
南京医科大学附属儿童医院/南京市儿童医院高水平医院建设基金(宁儿医[2025]5号)。
关键词
肥厚型心肌病
诊断
治疗
管理
儿童
hypertrophic cardiomyopathy
diagnosis
treatment
management
child
